Thromboembolism  >>  rivaroxaban  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
rivaroxaban / Generic mfg.
NCT01507051: Switching Study From Warfarin to Rivaroxaban

Completed
1
96
Europe
Warfarin (Coumadin), Rivaroxaban (Xarelto, BAY59-7939), Placebo, Vitamin K (Konakion)
Bayer, Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Venous Thrombosis
11/09
11/09
NCT01145859 / 2009-017313-30: Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects

Completed
1
59
US, Canada, Europe, RoW
Rivaroxaban (Xarelto, BAY59-7939)
Bayer, Janssen Research & Development, LLC
Venous Thrombosis, Pediatrics
07/15
07/15

Download Options